BackOdonate Therapeutics Overview

Odonate Therapeutics Operating Income

Operating Income for ODT.

Quarterly Operating Income

$-14017000.00
54.27% YoY

As of Sep 30, 2021

Annual Operating Income (TTM)

$-102323000.00
17.29% YoY

Trailing 12 months ending Sep 30, 2021

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)